Amendment to Retention Bonus Letter Agreement, dated November 13, 2024, by and between T2 Biosystems, Inc. and Michael Gibbs
Exhibit 10.3
AMENDMENT
TO
RETENTION BONUS LETTER AGREEMENT
This Amendment to Retention Bonus Letter Agreement is entered into as of November 13, 2024, by and between T2 Biosystems, Inc., a Delaware corporation having its principal place of business at 101 Hartwell Avenue, Lexington, Massachusetts 02421 USA (“T2 Bio”) and Michael Gibbs (“Employee”). Capitalized terms used herein without definition shall have the meaning ascribed thereto in the Retention Bonus Letter Agreement (as defined below).
Recitals
NOW THEREFORE, in consideration of the foregoing and the mutual agreements set forth below, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties to this Amendment agree to amend the Retention Bonus Letter Agreement in accordance with the terms thereof as follows:
“Subject to the terms of this letter agreement, including continued employment through the applicable date set forth below, the Retention Bonus will be paid to you by the Company in two installments. Within five (5) business days following June 30, 2024 (the “Initial Retention Date”) the Company shall pay you the amount of $40,000 and within five (5) business days following December 31, 2024 (the “Second Retention Date”) the Company shall pay you the amount of $40,000.”
[Signature Page Follows]
2
IN WITNESS WHEREOF, the parties have caused this Amendment to be executed by their duly authorized representatives below.
T2 BIOSYSTEMS, INC. |
|
| ||
By: | /s/ John Sperzel__________ |
| By: | /s/ Michael Gibbs |
|
|
|
|
|
Name: | John Sperzel |
| Name: | Michael Gibbs |
Title: | Chairman, President & CEO |
| Date: | November 13, 2024 |
3